Digital Twins in Healthcare Market Summary
- The digital twins in healthcare market size was valued at USD 2,094.73 million in 2024, and projected to reach USD 15,211.73 million by 2032.
- The digital twins in healthcare market is expected to grow at a CAGR of 28.17% by 2032.
Digital Twins in Healthcare Market Trends & Insights
- North America is projected to hold the largest share of the digital twins in healthcare market in 2024, driven by the rising prevalence of chronic diseases, a growing number of surgical procedures, and supportive regulatory policies from government agencies.
- Some of the key market players operating in the digital twins in healthcare market include Siemens Healthineers AG, IBM, Koninklijke Philips N.V., Oracle, Virtonomy GmbH, Microsoft, Unity Technologies, Verto Health, Dassault Systèmes, ANSYS, Inc., Twins Digital Services India Private Limited, SAP, NVIDIA Corporation, Exactcure, TCS, Unlearn.ai, Inc., PrediSurge, Q Bio, Cisco Systems, Inc., GE HealthCare, and others.
- In the type segment of the digital twins in healthcare market, the patient digital twin category is estimated to account for the largest market share in 2024.
Digital Twins in Healthcare Market Size and Forecasts
- 2024 Market Size: USD 2,094.73 million
- 2032 Projected Market Size: USD 15,211.73 million
- Growth Rate (2025-2032): 28.17% CAGR
- Largest Market: North America
- Fastest Growing Market: Asia-Pacific
- Market Structure: Moderately Concentrated
Key Factors Contributing to the Growth of the Digital Twins in Healthcare Market
-
Rising Demand for Personalized Medicine
Digital twins enable real-time simulation of patient-specific conditions, improving diagnosis, treatment planning, and therapy optimization.
-
Advancements in AI, IoT, and Big Data Analytics
Integration of AI, machine learning, and IoT devices enhances the accuracy and predictive power of digital twin models.
-
Growing Adoption of Remote Patient Monitoring
With the rise of telehealth, digital twins support continuous tracking and prediction of patient health outcomes.
-
Cost Reduction in Healthcare Delivery
Digital twins help optimize clinical workflows, reduce trial-and-error treatments, and minimize hospital readmissions, lowering overall costs.
-
Expanding Applications in Drug Discovery & Clinical Trials
Pharma companies use digital twins to model drug interactions and simulate trial outcomes, accelerating R&D.
-
Increasing Use in Hospital Operations & Asset Management
Healthcare providers leverage digital twins for facility management, equipment performance tracking, and predictive maintenance.
-
Government & Institutional Support
Growing funding for smart healthcare initiatives and digital transformation boosts adoption.
-
Rising Burden of Chronic Diseases
Higher prevalence of cardiovascular, neurological, and respiratory disorders increases demand for predictive healthcare tools.
Digital Twins in Healthcare Market by Type (Patient Digital Twins, Device Digital Twins, and Hospital Digital Twins), Technology (Artificial Intelligence (AI), Machine Learning (ML), and Internet of Things (IoT)), Application (Chronic Disease Management, Patient Monitoring, Surgical Simulation, Predictive Analysis, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World) is expected to grow at a robust CAGR forecast till 2032 owing to the growing prevalence of chronic disease and the increasing technological innovations and product launches by key market players.
The digital twins in healthcare market was valued at USD 2,094.73 million in 2024, growing at a CAGR of 28.17% during the forecast period from 2025 to 2032 to reach USD 15,211.73 million by 2032. The demand for digital twins in healthcare is primarily driven by the rising prevalence of chronic diseases such as cancer, cardiovascular conditions, and diabetes, and others. Increasing demand for personalized, data-driven care is enabling physicians to make more accurate treatment decisions. Additionally, the growing number of surgeries performed worldwide, along with ongoing technological innovations, new product launches, and advancements in predictive analytics, are key factors fueling market growth. These trends are expected to support strong and steady growth in the digital twins in healthcare market during the forecast period from 2025 to 2032.
Digital Twins in Healthcare Market Dynamics:
According to GLOBOCAN (2024), approximately 20 million new cancer cases were reported globally in 2022, with this number projected to rise to 32.6 million by 2045. In the WHO Eastern Mediterranean Region alone, over 788,000 cancer diagnoses were recorded in 2022, a figure expected to double to around 1.57 million by 2045 (WHO, 2024). This sharp increase in cancer incidence is driving the adoption of digital twin technologies in healthcare, particularly for applications like predicting tumor growth, simulating therapy outcomes, and enabling personalized treatment planning and early diagnosis.
Similarly, cardiovascular diseases are on the rise globally. Data from the British Heart Foundation (2024) highlighted that approximately 640 million people were affected by heart and circulatory diseases worldwide, with around 67 million new diagnoses each year. This surge is creating increased demand for cardiac surgical procedures, where digital twins are proving invaluable. These models enable real-time simulations of heart conditions, including virtual testing of interventions such as stent placements or valve implants, enhancing treatment precision and improving patient outcomes. Supporting this, a study published in the Annals of Thoracic Surgery (2024) estimated that over 1 million cardiac surgical procedures were performed globally each year.
The global diabetes burden is also escalating rapidly. According to the International Diabetes Federation (2023), 537 million adults aged 20–79 were living with diabetes in 2021, a number projected to rise to 643 million by 2030 and 783 million by 2045. This growing prevalence is accelerating the adoption of digital twin solutions that utilize real-time metabolic modeling. By leveraging continuous glucose and lifestyle data, digital twins help personalize insulin dosing, dietary plans, and early intervention strategies, ultimately improving glycemic control and increasing the chances of disease remission.
The rising volume of surgical procedures across all specialties further contributes to the growing demand for digital twins in healthcare. The World Health Organization (2023) reports that over 300 million surgeries are performed annually worldwide. In 2023 alone, the National Institutes of Health recorded more than 15.8 million surgical procedures globally. Regionally, data from the British Orthopaedic Association (2022) reported a peak of 42,000 orthopedic operations in the UK in 2022. Aesthetic surgeries are also on the rise, with the International Society of Aesthetic Plastic Surgery (ISAPS, 2024) reporting approximately 35 million such procedures performed globally in 2023.
This increasing surgical demand is boosting the deployment of digital twin solutions, as surgeons seek to simulate complex operations virtually, optimize operating room workflows, reduce complications, and enhance patient safety. These benefits are especially crucial in high-risk or highly specialized surgical domains.
In addition to the rising prevalence of chronic diseases and surgical interventions, technological advancements and product innovations are further propelling the market. For example, in September 2023, Dassault Systèmes launched “Emma Twin”, a digital avatar developed to showcase the power of virtual twins in advancing healthcare and shaping the future of medicine.
However, the high development & implementation costs and data privacy and security concerns, among others, are some of the key constraints that may limit the growth of the digital twins in the healthcare market.
Digital Twins in Healthcare Market Segment Analysis:
Digital Twins in Healthcare Market by Type (Patient Digital Twins, Device Digital Twins, and Hospital Digital Twins), Technology (Artificial Intelligence (AI), Machine Learning (ML), and Internet of Things (IoT)), Application (Chronic Disease Management, Patient Monitoring, Surgical Simulation, Predictive Analysis, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World)
In the type segment of the digital twins in healthcare market, the patient digital twin category is estimated to account for the largest market share in 2024. The growth of this category is mainly attributed to the growing prevalence of chronic diseases and the expanding range of applications and benefits associated with patient digital twin technologies.
According to data from NHS England (2022), approximately 920,000 individuals in the UK were living with heart failure, with 200,000 new cases reported annually. Similarly, the Heart Foundation (2024) reported that over 144,000 Australians (0.6% of the population) were affected by heart failure. The increasing global burden of such chronic conditions is significantly driving the demand for patient-centric digital twin solutions.
A key example of this technology is the Digital Twin of the Heart, developed by Siemens Healthineers AG. This innovation represents a personalized computational model of an individual’s heart, capable of simulating various health scenarios, diagnostic steps, and therapeutic interventions. Patient digital twins enable tailored treatments based on a person's unique biological makeup, lifestyle, and medical history. These models can simulate responses to different medications or interventions in advance, thereby reducing trial-and-error prescribing and minimizing the risk of adverse drug reactions or ineffective therapies.
Furthermore, patient digital twins enhance proactive healthcare by allowing clinicians to detect health risks and monitor disease progression before symptoms appear. They can predict flare-ups or relapses in chronic conditions such as asthma and diabetes, and help test treatment options and dosages in silico, offering a safer and more efficient therapeutic approach. In surgical applications, these digital twins support personalized pre-operative planning and real-time risk assessments, allowing surgeons to simulate procedures on virtual replicas of patients. This improves surgical precision, reduces complications, and enhances patient outcomes.
The rising number of patients affected by chronic diseases is prompting key industry players to invest in and develop advanced digital twin tools. For instance, in April 2025, Unlearn partnered with Trace Neuroscience to optimize ALS clinical trials. The collaboration involves the use of Unlearn’s Digital Twin Generator for ALS (ALS DTG) and its broader platform to support Trace Neuroscience's upcoming Phase 1/2 trial for amyotrophic lateral sclerosis (ALS).
Such innovations are fueling the rapid growth of the patient digital twin segment, thereby driving the overall expansion of digital twins in healthcare market.
North America is expected to dominate the overall digital twins in healthcare market:
North America is projected to hold the largest share of the digital twins in healthcare market in 2024, driven by several key factors. This regional dominance is primarily attributed to the rising prevalence of chronic diseases, a growing number of surgical procedures, and supportive regulatory policies from government agencies. Additionally, increased partnerships and collaboration among healthcare and technology companies for the development and launch of digital twin solutions are further fueling market growth in the region. Together, these factors solidify North America’s position as the dominant region in the global digital twins in healthcare market.
According to GLOBOCAN (2024), in 2022, cancer cases in the U.S. reached 2.38 million and were projected to rise to 2.79 million by 2030. The American Cancer Society (2025) also estimated 2.04 million new cancer cases in 2025. This surge is boosting demand for digital twins that offer personalized treatment planning, early detection, and therapy simulation.
Cardiovascular disease is another major driver. The CDC (2024) reported that in 2022, around 6.2 million adults in the U.S. had heart failure, and 20.5 million were living with coronary heart disease (CHD). Digital twin technology helps in early diagnosis, risk prediction, and tailored treatment simulations, enhancing cardiac care.
According to a report from the Centers for Disease Control and Prevention (CDC) published in 2023, approximately 6.7 million individuals aged 65 and older were living with Alzheimer’s disease in the United States, and this number was projected to reach 13.9 million by 2060. Digital twins are emerging as a promising tool in Alzheimer's disease (AD) research and care. They can be used to model disease progression, predict outcomes, personalize treatments, and potentially accelerate drug discovery and clinical trials.
The region is also experiencing a rise in surgical procedures. For example, the Government of Saskatchewan (2024) reported 6,000 surgeries performed in Canada during the 2023–2024 fiscal year. Digital twins support pre-surgical planning and simulations, improving precision and reducing complications.
Moreover, ongoing innovation by key players is accelerating market growth. In May 2024, Ontrak Inc. launched its Mental Health Digital Twin (MHDT), which combines data-driven insights with human empathy to provide personalized and effective mental health care. Additionally, digital twins are increasingly being used in medical device development. According to the National Institutes of Health (2025), the FDA cleared 69 medical devices in 2024 that were developed using digital twin technology, highlighting its growing role in healthcare innovation.
Therefore, the combination of a rising number of chronic diseases coupled with increasing surgical volumes, and technological innovations in the domain of healthcare digital twins is expected to significantly propel the growth of the digital twins in healthcare market in North America from 2025 to 2032.
Digital Twins in Healthcare Market Key Players:
Some of the key market players operating in the digital twins in healthcare market include Siemens Healthineers AG, IBM, Koninklijke Philips N.V., Oracle, Virtonomy GmbH, Microsoft, Unity Technologies, Verto Health, Dassault Systèmes, ANSYS, Inc., Twins Digital Services India Private Limited, SAP, NVIDIA Corporation, Exactcure, TCS, Unlearn.ai, Inc., PrediSurge, Q Bio, Cisco Systems, Inc., GE HealthCare, and others.
Recent Developmental Activities in the Digital Twins in Healthcare Market:
- In January 2025, Quibim announced $50 million in Series A financing, led by Asabys and Buenavista, to advance precision medicine using AI-powered imaging biomarkers. The company is developing digital twins at the organ and lesion level, with solutions such as QP-Brain, QP-Prostate, and QP-Liver, highlighting its commitment to personalized, data-driven healthcare.
- In November 2024, PrediSurge announced a collaboration with Medtronic to offer its technology to customers using Medtronic’s Endurant™ stent graft. PrediSurge’s patient-specific digital twin technology, powered by advanced AI, enables personalized predictive simulations to enhance endovascular aortic care, marking a significant step forward in precision treatment.
- In October 2023, FEops partnered with TeraRecon to accelerate the commercialization of FEops HEARTguide™, a unique cloud-based procedure planning solution in the structural heart space. Powered by digital twin technology, FEops HEARTguide™ enhances structural heart interventions by enabling personalized, data-driven planning for improved patient outcomes.
Key takeaways from the digital twins in healthcare market report study
- Market size analysis for current digital twins in healthcare market size (2024), and market forecast for 8 years (2025 to 2032)
- Top key product/technology developments, mergers, acquisitions, partnerships, and joint ventures happened over the last 3 years.
- Key companies dominating the digital twins in healthcare market.
- Various opportunities available for the other competitors in the digital twins in healthcare market space.
- What are the top-performing segments in 2024? How these segments will perform in 2032?
- Which are the top-performing regions and countries in the current digital twins in healthcare market scenario?
- Which are the regions and countries where companies should have concentrated on opportunities for digital twins in healthcare market growth in the coming future?
Target audience who can benefit from this digital twins in healthcare market report study
- Digital twins in healthcare product providers
- Research organizations and consulting companies
- Digital twins in healthcare-related organizations, associations, forums, and other alliances
- Government and corporate offices
- Start-up companies, venture capitalists, and private equity firms
- Distributors and traders dealing in digital twins in healthcare
- Various end-users who want to know more about the digital twins in healthcare market and the latest technological developments in the digital twins in healthcare market.
Frequently Asked Questions for the Digital Twins in Healthcare Market:
1. What are digital twins in healthcare?
Digital Twins in Healthcare refer to virtual replicas of patients, organs, or healthcare systems that are created using real-time data, artificial intelligence (AI), machine learning, and simulation technologies. These digital models are used to simulate, predict, and optimize health outcomes by mirroring the physical condition of a patient or system.
2. What is the market for digital twins in healthcare?
The digital twins in healthcare market was valued at USD 2,094.73 million in 2024, growing at a CAGR of 28.17% during the forecast period from 2025 to 2032 to reach USD 15,211.73 million by 2032.
3. What are the drivers for the digital twins in healthcare market?
The demand for digital twins in healthcare is primarily driven by the rising prevalence of chronic diseases such as cancer, cardiovascular conditions, and diabetes. Increasing demand for personalized, data-driven care is enabling physicians to make more accurate treatment decisions. Additionally, the growing number of surgeries performed worldwide, along with ongoing technological innovations, new product launches, and advancements in predictive analytics, are key factors fuelling market growth. These trends are expected to support strong and steady growth in the digital twins in healthcare market from 2025 to 2032.
4. Who are the key players operating in the digital twins in healthcare market?
Some of the key market players operating in the digital twins in healthcare market include Siemens Healthineers AG, IBM, Koninklijke Philips N.V., Oracle, Virtonomy GmbH, Microsoft, Unity Technologies, Verto Health, Dassault Systèmes, ANSYS, Inc., Twins Digital Services India Private Limited, SAP, NVIDIA Corporation, Exactcure, TCS, Unlearn.ai, Inc., PrediSurge, Q Bio, Cisco Systems, Inc., GE HealthCare, and others.
5. Which region has the highest share in the digital twins in healthcare market?
North America is projected to hold the largest share of the digital twins in healthcare market in 2024, driven by several key factors. This regional dominance is primarily attributed to the rising prevalence of chronic diseases, a growing number of surgical procedures, and supportive regulatory policies from government agencies. Additionally, increased partnerships and collaboration among healthcare and technology companies for the development and launch of digital twin solutions are further fueling market growth in the region. Together, these factors solidify North America’s position as the dominant region in the global digital twins in healthcare market
